Advent Life Sciences

Europe Legal Chronicle. October 17, 2022

Epitopea’s US$14 Million Financing to Advance Cancer Immunotherapeutics

By Giulia Di Palma

Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Europe Legal Chronicle. September 30, 2022

Proximie’s US$80 Million Series C Equity Financing

By Giulia Di Palma

Osborne Clarke advised Advent Life Sciences on the deal. Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, made a lead...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Europe Legal Chronicle. December 14, 2021

AviadoBio’s $80 Million Series A Financing

By Giulia Di Palma

Bristows advised AviadoBio’s seed investors. AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Europe. Europe Legal Chronicle. February 25, 2021